ATYR PHARMA
aTyr Pharma is a biotherapeutics company that discovers and develops protein biologics for human therapeutics. The company has established a dominant intellectual property estate surrounding Physiocrine-based compositions and potential therapeutic applications. aTyr’s key programs are focused on immunomodulation disorders in the areas of inflammation and immunity and are in preclinical development. The company's primary focus is ATYR1923, a clinical-stage product candidate which binds to the... neuropilin-2 receptor and is designed to down-regulate immune engagement in interstitial lung diseases. The privately held biotech was founded by The Scripps Research Institute Professor Paul Schimmel, a leading aminoacyl tRNA synthetase scientist, and is backed by top life sciences investors Alta Partners, Cardinal Partners, Domain Associates and Polaris Ventures.
ATYR PHARMA
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2005-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.atyrpharma.com
Total Employee:
51+
Status:
Active
Contact:
(858) 731-8389
Email Addresses:
[email protected]
Total Funding:
352.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Amunix
Amunix is a biopharmaceutical company intended to discover, design, and develop novel biologics, protein, and peptide therapeutics.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
MediciNova
MediciNova is a biopharmaceutical company that acquires and develops novel, small-molecule therapeutics.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Xeris Pharmaceuticals
Xeris Pharmaceuticals is a pharmaceutical company that develops therapies for patients in endocrinology, neurology, and gastroenterology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Viking Global Investors
Viking Global Investors investment in Post-IPO Equity - aTyr Pharma
Redmile Group
Redmile Group investment in Post-IPO Equity - aTyr Pharma
EcoR1 Capital
EcoR1 Capital investment in Post-IPO Equity - aTyr Pharma
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - aTyr Pharma
Solar capital
Solar capital investment in Post-IPO Debt - aTyr Pharma
Domain Associates
Domain Associates investment in Series E - aTyr Pharma
EcoR1 Capital
EcoR1 Capital investment in Series E - aTyr Pharma
Polaris Venture Capital
Polaris Venture Capital investment in Series E - aTyr Pharma
Alta Partners
Alta Partners investment in Series E - aTyr Pharma
Cardinal Partners
Cardinal Partners investment in Series E - aTyr Pharma
Key Employee Changes
Official Site Inspections
http://www.atyrpharma.com Semrush global rank: 3.33 M Semrush visits lastest month: 4.82 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
